# Use of Gou-Teng to Treat Patients With Mild Cognitive Impairment

> **NCT04532697** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 56 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- White Matter Hyperintensity

## Interventions

- **OTHER:** Uncaria Rhynchophylla (Gou-Teng)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04532697
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-24
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04532697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04532697, "Use of Gou-Teng to Treat Patients With Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04532697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*